<VariationArchive VariationID="2055366" VariationName="NM_018139.3(DNAAF2):c.820_821del (p.Ala275fs)" VariationType="Deletion" Accession="VCV002055366" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2105483" VariationID="2055366">
      <GeneList>
        <Gene Symbol="DNAAF2" FullName="dynein axonemal assembly factor 2" GeneID="55172" HGNC_ID="HGNC:20188" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="49625174" stop="49635244" display_start="49625174" display_stop="49635244" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="50091891" stop="50101947" display_start="50091891" display_stop="50101947" Strand="-" />
          </Location>
          <OMIM>612517</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018139.3(DNAAF2):c.820_821del (p.Ala275fs)</Name>
      <CanonicalSPDI>NC_000014.9:49634328:GAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="49634329" stop="49634330" display_start="49634329" display_stop="49634330" variantLength="2" positionVCF="49634328" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="50101047" stop="50101048" display_start="50101047" display_stop="50101048" variantLength="2" positionVCF="50101046" referenceAlleleVCF="TGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A275fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.50101048_50101049del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.50101048_50101049del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.49634330_49634331del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.49634330_49634331del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013070.1" sequenceAccession="NG_013070" sequenceVersion="1" change="g.5901_5902del">
            <Expression>NG_013070.1:g.5901_5902del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_129045.1" sequenceAccession="NG_129045" sequenceVersion="1" change="g.303_304del">
            <Expression>NG_129045.1:g.303_304del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083908.2" sequenceAccession="NM_001083908" sequenceVersion="2" change="c.820_821del">
            <Expression>NM_001083908.2:c.820_821del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077377.1" sequenceAccession="NP_001077377" sequenceVersion="1" change="p.Ala275fs">
            <Expression>NP_001077377.1:p.Ala275fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018139.3" sequenceAccession="NM_018139" sequenceVersion="3" change="c.820_821del" MANESelect="true">
            <Expression>NM_018139.3:c.820_821del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060609.2" sequenceAccession="NP_060609" sequenceVersion="2" change="p.Ala275fs">
            <Expression>NP_060609.2:p.Ala275fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018139.2" sequenceAccession="NM_018139" sequenceVersion="2" change="c.820_821delTC">
            <Expression>NM_018139.2:c.820_821delTC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018139.3(DNAAF2):c.820_821del (p.Ala275fs) AND Primary ciliary dyskinesia" Accession="RCV002910026" Version="3">
        <ClassifiedConditionList TraitSetID="8944">
          <ClassifiedCondition DB="MedGen" ID="C0008780">Primary ciliary dyskinesia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018139.3(DNAAF2):c.820_821del (p.Ala275fs) AND DNAAF2-related disorder" Accession="RCV003409967" Version="4">
        <ClassifiedConditionList TraitSetID="90155">
          <ClassifiedCondition>DNAAF2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19052621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24498942</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15219" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Primary ciliary dyskinesia</ElementValue>
                <XRef ID="Primary+ciliary+dyskinesia/5941" DB="Genetic Alliance" />
                <XRef ID="MONDO:0016575" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS244400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ciliary dyskinesia</ElementValue>
                <XRef ID="HP:0012265" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PCD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CILD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4484" />
                <XRef ID="4484" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301301</ID>
                <ID Source="BookShelf">NBK1122</ID>
              </Citation>
              <Citation Type="general" Abbrev="PCD Foundation, 2016">
                <ID Source="pmc">4912005</ID>
              </Citation>
              <XRef ID="244" DB="Orphanet" />
              <XRef ID="C0008780" DB="MedGen" />
              <XRef ID="MONDO:0016575" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS244400" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012265" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90155" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69730" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DNAAF2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DNAAF2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7685644" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="25160889|DNAAF2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004109348" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The DNAAF2 c.820_821delTC variant is predicted to result in a frameshift and premature protein termination (p.Ala275Profs*7). To our knowledge this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in DNAAF2 are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAAF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018139.2:c.820_821delTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DNAAF2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5953898" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="2636066|MedGen:C0008780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003265840" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19052621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24498942</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with DNAAF2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala275Profs*7) in the DNAAF2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAAF2 are known to be pathogenic (PMID: 19052621, 24498942).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAAF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.50101047_50101048del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0008780" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7685644" TraitType="Disease" MappingType="Name" MappingValue="DNAAF2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="DNAAF2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5953898" TraitType="Disease" MappingType="XRef" MappingValue="C0008780" MappingRef="MedGen">
        <MedGen CUI="C0008780" Name="Primary ciliary dyskinesia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

